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Abstract  18 
The peptidoglycan (PG) cell wall is an essential structure for the growth of most bacteria. However, 19 
many are capable of switching into a wall-deficient L-form state, which is resistant to antibiotics that 20 
target cell wall synthesis, under osmoprotective conditions, including host environments. L-form 21 
cells might have an important role in chronic or recurrent infections. Crucially, the cellular pathways 22 
involved in switching to and from the L-form state are still poorly understood. This work shows that 23 
the lack of cell wall or blocking its synthesis by β-lactam antibiotics, results in an increased flux 24 
through glycolysis. This leads to the production of reactive oxygen species (ROS) from the respiratory 25 
chain (RC), which prevents L-form growth. Compensation for the metabolic imbalance by slowing 26 
down glycolysis, activating gluconeogenesis, or depleting oxygen, enables L-form growth in Bacillus 27 
subtilis, Listeria monocytogenes and Staphylococcus aureus. These effects do not occur in 28 
Enterococcus faecium, which lacks the RC pathway. Our results collectively show that when cell wall 29 
synthesis is blocked under aerobic and glycolytic conditions the perturbation of cellular metabolism 30 
causes cell death. We provide a mechanistic framework for many anecdotal descriptions of the 31 
optimal conditions for L-form growth and non-lytic killing by β-lactam antibiotics.  32 
Many bacteria retain the ability to switch into a wall-deficient state called the L-form 1, which is 33 
completely resistant to antibiotics working specifically on cell wall synthesis, including β-lactams. L-34 
forms have been identified as antibiotic resistant organisms in samples from humans, and thus they 35 
might contribute to chronic or recurrent infections 2-4. Crucially, in both a free living Bacillus subtilis 36 
and a pathogenic Staphylococcus aureus, host lytic enzymes, especially lysozyme, can promote an L-37 
form switch that enables the organism to evade β-lactam action and continue proliferating 5. 38 
B. subtilis has been used as a tractable model system for studying the molecular biology of L-forms 39 
4,6. Inhibition of de novo PG synthesis traps the membrane-bound L-form inside the original PG wall. 40 
Autolytic enzymes or exogenous PG hydrolases, such as lysozyme, can degrade the wall, enabling L-41 
form to escape, and survival in isotonic environments 5,7 (Supplementary Fig. 1a). L-form 42 
proliferation seems to involve a simple biophysical effect based on an increased rate of surface area 43 
to volume synthesis, driving cell shape deformations that lead to spontaneous scission 8. However, 44 
because ROS originating from the RC pathway are abnormally increased in the cell-wall-deficient 45 
cells, reduction of RC activity or high levels of ROS scavengers are normally required to support 46 
robust L-form growth 9 (Supplementary Fig. 1a). L-form growth of the Gram-negative bacterium 47 
Escherichia coli was also stimulated under anaerobic conditions or by adding a ROS scavenger, 48 
suggesting that oxidative damage might be an important impediment to L-form growth in a wide 49 
range of bacteria 9-11. Nevertheless, it remained unclear why the L-form transition should result in 50 
increased ROS.  51 
ROS is generated as a natural side effect of cellular metabolism and aerobic respiration. The PG wall 52 
synthesis pathway is one of the major drains on carbon in the central metabolic pathway (Fig. 1a), so 53 
we favor a model in which a block in PG synthesis results in re-routing of phospho-sugars towards 54 
catabolic rather anabolic pathways. This could, in turn, result in stimulating flux into the TCA cycle, 55 
leading to increased generation of ROS as a by-product of the metabolism of molecular oxygen in 56 
the RC pathway.  57 
Here, we show that the abnormal generation of ROS in the L-form transition correlates with an 58 
increase in glycolytic activity in B. subtilis and likely other Gram-positive bacteria, including 59 
pathogens. Moreover, we show that a reduction of glycolytic activity or activation of 60 
gluconeogenesis, which acts as the reverse of glycolysis, can compensate for the metabolic 61 
imbalance, reducing the oxidative damage and thus promoting L-form growth, thereby evading β-62 
lactam killing. Consistent with this model, the glycolysis-mediated killing did not occur during the L-63 
form transition in the pathogen Enterococcus faecium, which lacks the RC pathway 12,13. Our results 64 
show how a specific metabolic diversion induced by β-lactam antibiotics contributes to cell killing in 65 
Gram-positive bacteria, and provide an understanding of the conditions influencing the ability of 66 
cells to grow in the L-form state.  67 
 68 
Results  69 
Repression of glycolytic activity promotes L-form growth 70 
Figure 1b and supplementary figures 1b-e recapitulate our previous findings that repression of the 71 
murE operon (containing genes for several steps in the PG precursor, lipid II, pathway) induces an 72 
efficient L-form switch, when the cells have an ispA mutation (or other mutations which affect the 73 
RC pathway) but not in ispA+ cells 6,8. The ispA product is thought to contribute to the synthesis of 74 
menaquinone, an electron carrier in the RC pathway 9,14 (Fig. 1a). To test whether the requirement 75 
for the ispA mutation was due to glycolytic activity, we put the gapA gene, which encodes 76 
glyceraldehyde 3-phosphate dehydrogenase, an essential component of the glycolytic pathway 15 77 
(Fig. 1a), under IPTG control in the ispA+ background. In the normal walled state (MurE ON), 78 
repression of gapA partially impaired growth on isotonic NA/sucrose plates (nutrient agar containing 79 
0.5 M sucrose) (Fig. 1c, MurE ON / GapA OFF), consistent with expectation that glycolysis is required 80 
for efficient growth of the walled cells under these culture conditions. When the precursor pathway 81 
was blocked (MurE OFF), no L-form growth was observed in the presence of IPTG (Fig. 1c, MurE OFF 82 
/GapA ON). However, growth did occur in the absence of IPTG, and phase contrast microscopy 83 
showed the presence of heterogenous spheroidal L-forms on the plates (Fig. 1c, MurE OFF / GapA 84 
OFF), similar to those of the ispA- strain (Fig. 1b). Thus, reduction of glycolytic activity can substitute 85 
for ispA mutation in promoting L-form growth.  86 
Metabolic re-routing prevents L-form growth 87 
Uridine 5’-diphospho-N-acetylglucosamine (UDP-GlcNAc), an essential precursor of lipid II, is 88 
generated from fructose-6-phosphate, a glycolytic intermediate (Fig. 1a), through the action of the 89 
glmS, glmM and gcaD gene products (Fig. 1d). The glmS riboswitch is a ribozyme that self-cleaves 90 
upon binding glucosamine-6-phosphate, the product of the enzyme encoded by glmS 16 (Fig. 1d). We 91 
expected that blockage of the UDP-GlcNAc pathway by repressing glmM and indirectly also glmS 92 
should result in a re-routing of glucose metabolism towards glycolysis. To test the effects of this 93 
metabolic switch on L-form growth, we put the glmM gene under IPTG control in the LR2 strain (Pxyl-94 
murE ispA-). In the presence of IPTG (GlmM ON) but no xylose (MurE OFF), efficient L-form growth 95 
was observed (Fig. 1e, left, control). However, growth did not occur when the expression of glmM 96 
was repressed (Fig. 1e, right, control). If the growth defect was caused by increased ROS production 97 
from the RC pathway through increased glycolytic activity, it should be suppressed by reducing RC 98 
activity. As shown in Figure 1a, ndh, qoxB and ctaB gene products are involved in the RC system: ndh 99 
encodes a major NADH dehydrogenease 17; qoxB encodes cytochrome aa3 quinol oxidase subunit I 100 
18; and ctaB encodes heme O synthase 19. We examined the effects of mutations in these genes on L-101 
form growth with glmM repression and found that they all rescued the growth defect (Fig. 1e). 102 
Similar results were obtained by introducing a mutation in mhqR (Fig. 1e), which encodes a 103 
transcriptional repressor for genes induced by the thiol-specific oxidative and/or electrophile stress 104 
response 20 (Fig. 1a). Thus, carbon flux through glycolysis seems to be a serious impediment to L-105 
form growth and it can be bypassed either by downregulating RC activity, or upregulating oxidative 106 
stress response genes.  107 
Inhibition of the sugar uptake system promotes L-form growth 108 
Sucrose is a disaccharide sugar consisting of glucose and fructose that has frequently been used in L-109 
form culture media to provide an isotonic environment. Many bacteria, including B. subtilis, take up 110 
sucrose by the phosphotransferase system (PTS) and consume this through glycolysis to provide 111 
cellular energy 21. In B. subtilis, levansucrase and endolevanase can cleave sucrose externally to 112 
glucose and fructose 22, which are then also utilised via the PTS pathway and glycolysis. According to 113 
our model, limiting the uptake of those glycolytic sugars should promote L-form growth by reducing 114 
glycolytic flux in the MurE OFF background. The PTS consists of two general components, enzyme I 115 
(EI) and phosphocarrier protein (HPr), and a suite of sugar-specific transporters (EII) 23. We 116 
constructed mutants for the sucrose (ΔsacP), glucose (ΔptsG) and fructose (ΔfruA and ΔlevD) 117 
transporters, respectively, and an IPTG-inducible mutant for the co-regulated universal EI and Hpr 118 
proteins (Pspac-ptsH-ptsI operon) in Pxyl-murE background. In the walled state (MurE ON), all of the 119 
strains grew well, except the ptsHI mutant, which showed slightly slower growth on NA/sucrose 120 
plates (Fig. 2a and Supplementary Fig. 2a), suggesting that not only sucrose but also other sugars in 121 
the plate are utilized as carbon sources under these conditions. When PG synthesis was blocked 122 
(MurE OFF), none of the single deletion mutants showed significant growth (Fig. 2a, middle and 123 
right). However, the ptsHI mutant showed efficient L-form growth (Fig. 2b) when repressed (Fig. 2a, 124 
middle) but not when induced (right panel). Thus, inhibition of uptake for glycolytic sugars by 125 
repressing the PTS system promotes L-form growth without the need for the ispA mutation, likely by 126 
reducing glycolytic flux.  127 
Since the PTS is also crucial for the signal-transduction pathways in carbon catabolite repression 128 
(CCR) 23, we tested the effects of deleting ccpA, which encodes a key transcriptional factor in the CCR, 129 
but no significant stimulation of L-form growth was observed (Supplementary Fig. 2a). 130 
Contrasting effects of gluconeogenic carbon sources on L-form growth 131 
Figures 2c and d show that glucose (NA + 0.5M glucose), which is a highly favoured glycolytic carbon 132 
source in many bacteria, could substitute for sucrose in providing osmotic support for B. subtilis L-133 
form growth, but again this required a mutation such as ispA. These findings were largely 134 
independent of the growth medium because similar results were obtained when the cells were 135 
cultured on minimal medium (MM) containing 0.5 M sucrose or glucose as the sole carbon source 136 
(Supplementary Fig. 2b and c). Again L-form growth was readily observed in the ispA mutant, but not 137 
in the ispA+ background, confirming that the reduction of RC activity by the ispA mutation is crucial 138 
for B. subtilis L-form growth under glycolytic conditions. 139 
Gluconeogenesis is a metabolic pathway that results in the generation of glucose from certain non-140 
carbohydrate carbon substrates, including malate and succinate, and the reactions occur much like 141 
the reverse of glycolysis. Imported malate enters the TCA cycle, but only 10% is respired via the TCA 142 
cycle in B. subtilis 24. The majority is converted to phosphoenolpyruvate and pyruvate, resulting in an 143 
increased gluconeogenic flux and overflow metabolism. Similarly, it has been shown that flux 144 
through the TCA cycle is also reduced in the presence of succinate 25. To test whether increased flux 145 
through gluconeogenesis (and/or overflow metabolism) could counteract the inhibitory effect of 146 
glycolysis on L-form growth, we streaked Pxyl-murE strains with or without an ispA mutation on NA 147 
plates containing 0.5 M malate or succinate: L-form growth occurred efficiently even without the 148 
ispA mutation (Fig. 2c and d). Similar results were obtained on MM plates (Supplementary Fig. 2b 149 
and c). Thus, a reduction of RC activity by the ispA mutation is not required for L-form growth under 150 
gluconeogenic conditions. 151 
L-form growth does not require mutational changes under gluconeogenic conditions  152 
β-lactams, including penicillin G (PenG), remain widely used antibiotics, which target the penicillin-153 
binding proteins that assemble the PG wall 26. We recently discovered that innate immune PG 154 
hydrolases, such as lysozyme, can rescue various Gram-positive bacteria from β-lactam killing by 155 
converting them to L-forms5. Supplementary Figures 1b-e and 2d show that the promotion of L-form 156 
growth by combined treatment with PenG and lysozyme (NB these cells were murE+) still required an 157 
ispA mutation or other mutations in genes acting on the RC pathway under aerobic glycolytic 158 
conditions. However, under gluconeogenic conditions, a completely wild type (i.e. murE+, ispA+) B. 159 
subtilis strain could be switched into the L-form state by PenG and lysozyme. As shown in Figure 3a, 160 
the presence of PenG blocked B. subtilis growth on NA/succinate plates (because the L-form 161 
protoplast remains trapped inside the cell 5), but a lawn of small colonies was readily detectable on 162 
plates containing both PenG and lysozyme after 2 days of incubation (because the lysozyme enables 163 
the protoplast to escape from the cell and initiate L-form growth 5). Phase contrast microscopy of 164 
the smaller colonies showed the presence of heterogeneous spheroidal L-forms (Fig. 3b, ii). The 165 
longer incubation also promoted the emergence of several larger colonies on plates (Fig. 3a, i), 166 
which appeared to contain walled cells with typical rod-shaped morphology (Fig. 3b, i). These 167 
presumably arose by reversion from L-forms when the antibiotic selection decayed, as described 168 
previously 5,27. Similar results were observed on succinate plates containing a cephalosporin β-lactam, 169 
cephalexin, except that fewer revertant colonies were evident (Supplementary Fig. 2e). Thus, under 170 
gluconeogenic conditions in the presence of lysozyme, wild type B. subtilis cells can escape from β-171 
lactam killing by switching to an L-form state without the need for any mutational change. 172 
Time-lapse microscopy was used to view the L-form switch in a wild-type strain. Under glycolytic 173 
conditions in the presence of PenG, addition of lysozyme promoted the emergence of L-forms within 174 
30 min, but they did not grow and frequently lysed (Fig. 3c and Supplementary Video 1). Although 175 
we occasionally observed successful L-form growth (Fig. 3c, red arrows), they eventually lysed 176 
(asterisk at 500 min). In contrast, under gluconeogenic conditions, L-forms emerged from the walled 177 
cells and propagated in a typical manner (Fig. 3d and Supplementary Video 1).  178 
To test whether the failure of L-form growth under glycolytic conditions was due to oxidative 179 
damage, we took advantage of a fluorescent fatty acid analogue, C11-BODYPY581/591, which has been 180 
used as an indicator of oxidative damage to lipids 9,28. The probe is incorporated into membranes, 181 
and the fluorescent properties shift from red to green upon free radical-induced oxidation. In wild-182 
type B. subtilis walled cells exponentially growing in NB/glucose medium, the cells exhibited a 183 
regular and smooth red fluorescence at the cell surface, but no clear green fluorescence was 184 
detectable (Fig. 3e, No addition). In contrast, green fluorescence was readily detectable in cells 185 
treated with PenG and lysozyme (Fig. 3e, PenG/Lys), suggesting oxidative damage to lipids in L-forms 186 
under glycolytic conditions. Crucially, such a fluorescent shift was not observed in L-forms cultured 187 
under gluconeogenic conditions (Fig. 3f).  188 
Increased carbon flux through glycolysis generates ROS toxicity  189 
The above results suggested that the generation of L-forms from walled cells and/or L-form growth 190 
causes a perturbation in cellular metabolism under glycolytic conditions, leading to ROS-mediated 191 
cell death (Supplementary Fig. 3a). To test this, we carried out 13C-based metabolic analysis. B. 192 
subtilis wild-type or ispA- cells were pre-cultured in NB containing 0.4 M glucose medium to obtain 193 
sufficient biomass and then transferred to fresh 0.4 M glucose medium containing 20 % universally 194 
13C-labelled (U-13C) glucose in the presence or absence of PenG and lysozyme. Pyruvate is the end 195 
product of glycolysis, and previous work has shown that B. subtilis excretes excess pyruvate during 196 
growth on glycolytic substrates 29. Although no significant changes occurred in the pool size of 197 
intracellular pyruvate (Fig. 4a), we observed increased extracellular pyruvate in the presence of 198 
PenG and lysozyme (Fig. 4b). This finding provided direct support for the idea that flux through 199 
glycolysis is increased during L-form growth.  200 
Bacillithiol (BSH) plays an important role in detoxification of ROS 30 and promotion of L-form growth 201 
under aerobic glycolytic conditions (Supplementary Fig. 3b-d) 9. We analysed the samples used for 202 
the above experiments and found that intracellular BSH levels were significantly reduced in the wild-203 
type cells treated with PenG and lysozyme (Fig. 4c and Supplementary Fig. 4), suggesting that BSH is 204 
consumed due to the accumulation of ROS. However, the reduction did not occur in the ispA mutant 205 
cells (Fig. 4 and Supplementary Fig. 4), again consistent with the idea that increased flux through 206 
glycolysis due to the inhibition of PG synthesis causes increased ROS generation from the RC 207 
pathway, leading to cell death.  208 
Gluconeogenic growth protects S. aureus and L. monocytogenes from β-lactam killing  209 
We examined whether these observations held also for a pathogenic Gram-positive bacterium S. 210 
aureus. Here, we replaced lysozyme with lysostaphin, a more effective hydrolytic enzyme for S. 211 
aureus PG 31. As shown in Figures 5a and b, no growth was seen on either glucose or succinate plates 212 
containing PenG. However, L-form growth was readily detectable on succinate plates with PenG and 213 
lysostaphin but not on glucose plates. Note that although we and others have reported that S. 214 
aureus L-form growth does occur on complex rich medium containing sucrose as osmoprotectant 215 
5,27,32,33, that L-form growth requires uptake and metabolism of glycerol, which is a substrate for 216 
gluconeogenesis 32, suggesting that sucrose may not be the primary carbon source under those 217 
conditions. 218 
PenG prevents PG assembly and is generally thought to induce explosive cell lysis under classical 219 
microbiological culture conditions, which are mainly hypotonic. Although, under osmoprotective 220 
conditions, the explosive death is largely suppressed, bacteria still die 5, by mechanisms that have 221 
not yet been resolved. Given the above results, we wondered whether gluconeogenic growth could 222 
also protect walled cells from PenG killing in isotonic medium. We cultured S. aureus walled cells in 223 
nutrient broth (NB) containing 0.5 M glucose (Glu) or succinate (Suc). The growth arrest was induced 224 
in both cultures shortly after addition of PenG (Fig. 5c, left). Although no significant changes in 225 
optical density (OD) occurred in the succinate culture following PenG treatment, prolonged 226 
incubation of the glucose culture resulted in a severe decrease in OD. In parallel with this, the colony 227 
forming units (CFU) of the glucose culture decreased over time in the presence of PenG and had 228 
dropped at least 1,000-fold after overnight incubation (Fig. 5e and f, and Supplementary Table 2). In 229 
contrast, in the succinate culture CFU fell no more than 10 fold after overnight incubation with PenG 230 
(Fig. 5e and f, and Supplementary Table 2). It thus appears that the efficiency of PenG killing in 231 
walled cells is greatly reduced under gluconeogenic conditions. This suggests that oxidative damage 232 
through glycolysis contributes greatly to PenG killing in walled S. aureus. 233 
Consistent with a key role for lysozyme in the switch to L-form growth upon β-lactam treatment, the 234 
OD of the succinate culture was significantly increased by combined treatment with PenG and 235 
lysostaphin (Fig. 5c, right, and d). However, in the glucose culture, rapid cell death occurred (Fig. 5c, 236 
right). We do not fully understand the mechanism of the rapid death but the glycolysis-mediated 237 
killing via oxidative damage or other mechanisms, such as futile cycling of PG synthesis and turnover, 238 
as occurs in E. coli 34, might be enhanced by stripping the PG wall. Nevertheless, those killing effects 239 
are largely counteracted under gluconeogenic conditions, leading to robust L-form growth that can 240 
evade β-lactam action.  241 
We then examined another pathogenic Firmicute, Listeria monocytogenes that is naturally resistant 242 
to lysozyme due to N-deacetylation or O-acetylation on the PG wall: elimination of the PG 243 
modification by use of a pgdA/oatA double mutant results in sensitivity to lysozyme 35,36. As shown in 244 
Figures 6a and b, formation and significant growth of L. monocytogenes L-forms did not occur on 245 
glucose plates containing PenG and lysozyme. In contrast, L-form colonies appeared on succinate 246 
plates after 2 days, showing that Listeria behaves similarly to B. subtilis and S. aureus in the effects of 247 
glycolytic vs gluconeogenic substrates. Note, also, that L-form growth was much more abundant for 248 
the pgdA/oat double mutant than for the wild type (Fig. 6a, Succinate, PenG/Lys), providing further 249 
evidence for the importance of cell wall degradation in L-form switching and protection from β-250 
lactam killing 5.  251 
Lack of the RC pathway allows escape from glycolysis-mediated β-lactam killing  252 
Finally, we examined Enterococcus faecium, which is also a pathogenic Firmicute but is strictly 253 
fermentative and completely lacks the RC pathway 12,13. Crucially, significant E. faecium L-form 254 
growth was seen not only on succinate plates but also on glucose plates containing PenG and 255 
lysozyme within 2 days of incubation (Fig. 6c). Presumably, lack of the RC pathway enables E. 256 
faecium to escape from β-lactam killing by switching to the L-form state even under glycolytic 257 
conditions. 258 
 259 
Discussion 260 
β-lactam antibiotics inhibit bacterial cell wall assembly and it is generally assumed that the main 261 
killing effect arises from loss of cell wall integrity, leading to explosive lysis. However, this kind of 262 
lysis does not seem generally to occur for many Gram-positive bacteria, even under non- 263 
osmoprotective (hypotonic) conditions: the bacteria are still prevented from growing and die by 264 
other mechanisms 5,37. Kohanski et al. have proposed a crucial role for ROS 38, which are generated 265 
as a natural side effect of aerobic respiration, in antibiotic-mediated killing of bacteria, including that 266 
arising from β-lactam treatment, although the extent to which this is responsible for cell killing 267 
remains controversial 39,40. Nevertheless, recent studies that reveal an important role for cellular 268 
metabolism in β-lactam killing further support the involvement of ROS as a metabolic by-product 41-269 
43. Our results now provide a possible mechanism for this effect. We show that blocking the cell wall 270 
pathway stimulates glycolytic flux, leading to ROS production via aerobic respiration (Fig. 1a). It is 271 
probably not surprising that the inhibition of cell wall synthesis results in dramatic changes in cell 272 
physiology because wall synthesis is a major drain on cellular resources, especially in Gram-positive 273 
bacteria where it comprises 10-20% of total cell mass. Crucially, our results appear to show that 274 
physiological compensation for the metabolic imbalance, by reducing glycolytic activity or activating 275 
gluconeogenesis, moderates the β-lactam toxicity, leading to the proliferation of wall-free L-form 276 
bacteria in the presence of lysozyme. The persistent growth during β-lactam treatment under 277 
glycolytic conditions of E. faecium, which naturally lacks a respiratory chain 12,13, provides strong 278 
support for this view (Fig. 6c). The physiological effects we have uncovered, especially in relation to 279 
the sensitivity of cells to intrinsically produced ROS, will be important for efforts to engineer 280 
simplified or artificial cells. The work suggests that the utilization of aerobic respiration comes at a 281 
potentially serious cost, and that in many organisms cellular metabolism is finely balanced to 282 
provide maximum energetic benefit. Perturbations of key central pathways, or in the future, 283 
incorrect design of metabolic pathways, may have seriously damaging consequences for the cell.  284 
In many diverse bacteria, the L-form state can be induced experimentally by treatment of cells with 285 
antibiotics and/or lytic enzymes that inhibit cell wall synthesis 2-5. A variety of protocols for 286 
generating L-forms to specific lineages have been described through decades of research, and those 287 
culture methods often involve anaerobic conditions10,44, consistent with a role for oxygen toxicity in 288 
L-form generation. Our genetic experiments have now provided some clarity on the physiological 289 
changes responsible for this effect; thus, inhibition of the uptake of glycolytic sugars, reduction of 290 
glycolytic activity, or reduction of RC activity can all work in promoting L-form growth under aerobic 291 
glycolytic conditions. It seems likely that utilization of sugar-phosphate intermediates through 292 
glycolysis results in an increased generation of ROS from the RC pathway, which then prevents L-293 
form growth. Stimulation of L-form growth by gluconeogenic growth or oxygen depletion, without 294 
the need for any mutational changes provides further support for this view (Fig. 3 and 295 
Supplementary Fig. 3).  296 
Since blocking cell wall synthesis eliminates the wall, its precursors and turnover products, which 297 
could normally act as ROS scavengers, it is formally possible that loss of these molecules increases 298 
sensitivity to normal levels of ROS. However, we do not favour this idea at present because cells 299 
treated with β-lactam but no lysozyme, and which therefore still possess both wall and precursors, 300 
nevertheless suffer from ROS toxicity 38. Also, growth of L-forms lacking a wall and blocked for 301 
precursor synthesis is strongly influenced by modulation of the glycolytic pathway (Fig. 1). It remains 302 
to be determined how the increased flux through glycolysis affects the RC pathway thereby 303 
impacting on L-form growth. 304 
Our results also reveal that the avoidance of β-lactam killing by switching to the L-form state 305 
depends on two key factors; i) escape from the cell wall sacculus – which can be effected by 306 
exogenous lytic enzymes, and ii) avoidance of ROS toxicity – which, via reduced glycolytic flux, is 307 
suppressed by growth on gluconeogenic carbon substrates (or lack of an RC). These findings show 308 
that the L-form transition can be supported, for a wide range of bacteria, perhaps including both 309 
free living and pathogenic organisms, by conditions found in the natural environment. Indeed, 310 
historically, L-form isolation has been reported from a wide range of sites including animal, human 311 
or plant hosts, as well as the natural environment 2-5. Although the possible role of L-forms in 312 
infectious diseases is presently unclear, β-lactam treatment could effectively facilitate L-form 313 
generation in certain niches within the human body because immune PG hydrolases and 314 
gluconeogenic substrates, such as lactate, glycerol and amino acids, are abundantly present. Finally, 315 
many antibiotics, including penicillin, work by attacking the bacterial cell wall. Our understanding of 316 
the physiological changes that are generated by the inhibition of cell wall synthesis, together with 317 
their implications for L-form generation and survival should prompt renewed interest into the 318 
possible role of L-forms in persistent or recurrent infections. 319 
 320 
Methods 321 
Bacterial Strains and Growth Conditions 322 
The bacterial strains in this study are listed in Supplementary Table 3. Nutrient broth (NB, Oxoid) and 323 
agar (NA, Oxoid) was used for bacterial growth at 30°C. Bacterial L-forms were induced and grown 324 
on osmoprotective medium composed of 2x magnesium-sucrose-maleic acid (MSM) pH7 (40 mM 325 
magnesium chloride, 1 M sucrose, and 40 mM maleic acid) mixed 1:1 with 2x NA, or 2x minimal 45 326 
(0.4% ammonium sulfate, 2.8% dipotassium phosphate, 1.2% potassium dihydrogen phosphate, 327 
0.2% sodium citrate dehydrate, 0.04% magnesium sulphate) medium supplemented with 20 µg/ml 328 
tryptophane, 0.1% yeast extract, 1 µg/ml ferric ammonium citrare, 0.1% glutamic acid, 0.02% 329 
casamino acids and 1% agar. 1 M sucrose in 2x MSM was replaced by 1 M glucose, malate or 330 
succinate as necessary. Supplements, 1 mM IPTG or 1% xylose were added to media when required, 331 
and also antibiotics were added at the following concentrations: 1 µg/ml erythromycin, 200 µg/ml 332 
PenG, 100 µg/ml cephalexin, 100 µg/ml lysozyme and/or 10 µg/ml lysostaphin. 1 µg/ml 8J (FtsZ 333 
inhibitor) 46 was used to prevent the growth of walled cells when required 8. Anaerobic growth 334 
condition was maintained using anaerobic atmosphere generation bags (AnaeroGenTM, Oxoid) in an 335 
anaerobic jar for growth on plates. 10 mM Nitrate and 0.1% glutamic acid were added for B. subtilis 336 
growth under anaerobic conditions. For growth curve and time course CFU measurement, overnight 337 
cell cultures in NB were diluted at 10-2 into fresh NB/glucose or succinate and incubated at 30°C with 338 
shaking for several hours, and the exponential cell cultures (optical density 600 nm of about 0.1) 339 
were prepared for the experiments. The exponential cell cultures were incubated at 30°C without 340 
shaking. 341 
 342 
Construction of IPTG-Inducible gapA gene, ptsHI operon and glmM gene  343 
To construct the IPTG-inducible gapA mutant, the first 200-300 bp of the gapA gene containing 344 
Shine-Dalgarno sequence was amplified by PCR from genomic DNA of the B. subtilis strain 168CA 345 
using the primers pM4SD-gapA-F and pM4-gapA-R (Supplementary Table 2), then cloned between 346 
the EcoRI and BamHI sites of plasmid pMutin4 47, creating pM4-Pspac-gapA. The resulting plasmid was 347 
introduced into the strain BS115 to generate YK1571 (Supplementary Table 2). In this strain, the full-348 
length gapA gene is expressed from the IPTG-inducible promoter Pspac, but the growth is not fully 349 
complemented, suggesting insufficient expression to compensate for the native levels of GapA. We 350 
therefore introduced a second copy of PspacHY-gapA fusion in the strain YK1571. The gapA gene 351 
containing the Shine–Dalgano sequence was amplified by PCR from genomic DNA of B. subtilis strain 352 
168CA, then cloned between the XbaI and SphI sites of plasmid pPL82 48, creating pPL82–gapA. The 353 
resulting plasmid was used to generate YK1621 in which the full-length gapA are expressed from the 354 
IPTG-inducible promoter PspacHY at the amyE locus on the chromosome (Supplementary Table 2).  355 
To construct the IPTG-inducible ptsHI mutant, the first 200~300 bp of the ptsH gene containing 356 
Shine-Dalgarno sequence was amplified by PCR from genomic DNA of the B. subtilis strain 168CA 357 
using the primers pM4SD-ptsHI-F and pM4-ptsHI-R (Supplementary Table 2), then cloned between 358 
the EcoRI and BamHI sites of plasmid pMutin4 47, creating pM4-Pspac-ptsHI. The resulting plasmid was 359 
introduced into the strain BS115 to generate YK1601 (Supplementary Table 2). In this strain, the full-360 
length ptsHI operon is expressed from the IPTG-inducible promoter Pspac.  361 
To construct the IPTG-inducible glmM mutant, the first 200~300 bp of the glmM gene containing 362 
Shine-Dalgarno sequence was amplified by PCR from genomic DNA of the B. subtilis strain 168CA 363 
using the primers pM4SD-glmM-F and pM4-glmM-R (Supplementary Table 2), then cloned between 364 
the EcoRI and BamHI sites of plasmid pMutin4 47, creating pM4-Pspac-glmM. The resulting plasmid 365 
was introduced into the strain LR2 to generate YK1563 (Supplementary Table 2). In this strain, the 366 
full-length glmM is expressed from the IPTG-inducible promoter Pspac. DNA manipulations and 367 
transformations were carried out using standard methods. 368 
 369 
Construction of disruption mutants. 370 
To construct the ptsG, sacP, fruA and levD disruption mutant, an internal segment of those genes 371 
were amplified by PCR from the B. subtilis strain 168CA genomic DNA using the primers in each case 372 
Supplementary Table 2), then cloned between the EcoRI and BamHI sites of plasmid pMutin4 47, 373 
creating pMutin4-ptsG, sacP, fruA and levD. The resulting plasmids were introduced into the strain 374 
BS115 to generate disruption mutants (Supplementary Table 2). DNA manipulations and 375 
transformations were carried out using standard methods. 376 
 377 
Microscopic Imaging 378 
For snapshot live-cell imaging, cells were mounted on microscope slides covered with a thin film of 379 
1 % agarose in water, or NB/MSM for L-forms. Images were acquired with a Sony Cool-Snap HQ2 380 
cooled CCD camera (Roper Scientific) attached to a Zeiss Axiovert 200M, or a Rolera EM-C2 (Q-381 
imaging) camera attached to a Nikon TiE microscope, and analysed using Metamorph (Molecular 382 
Devices). For time lapse imaging, 300 μL of exponentially growing B. subtilis walled cells in 383 
NB/glucose or succinate media were placed on 35 mm sterile glass bottom microwell dishes (ibidi 384 
GmbH, Munich, Germany), which were pre-coated with 2 mg/ml bovine serum albumin (BSA), and 385 
incubated for 5 min. The dishes were centrifuged at 100 g for 2 min using a Beckman Allegra X-12R 386 
centrifuge. Non-adherent cells were removed, and a thin layer of NB/g with 0.2% agar 387 
bacteriological (Oxoid), 100 µg/ml PenG and lysozyme was placed on the top of the dishes. The 388 
dishes were placed on the microscope stage at 30°C. Images were acquired with a Sony Cool-Snap 389 
HQ2 cooled CCD camera (Roper Scientific) attached to a Zeiss Axiovert 200M, and analyzed using 390 
Metamorph (Molecular Devices). Pictures and videos were prepared for publication using ImageJ 391 
(https://imagej.nih.gov/ij) and Adobe Photoshop. 392 
 393 
Lipid peroxidation 394 
Lipid oxidation was detected using a fluorescent probe (C11-BODIPY581/591; Life Technologies) as 395 
described previously 9. Exponentially growing B. subtilis walled cells were cultured in NB/glucose or 396 
succinate media at 37°C, and then 5 μM C11-BODIPY581/591 was added to the culture and incubated 397 
for 1 hr at 30°C before being used for microscopic analysis. For L-forms, 100 µg/ml PenG and 398 
lysozyme were added to the cultures with exponentially growing B. subtilis walled cells and 399 
incubated for 1 hr at 37°C. The cultures were further incubated for several hours at 30°C without 400 
shaking, and then 5 μM C11-BODIPY581/591 was added to the culture. 401 
 402 
Metabolome analysis 403 
For metabolome analysis nutrient broth (Difco) supplemented with 5 g/L NaCl and 0.4M glucose was 404 
used (NBG). The NBG was supplemented with 15 g/L agar (NAG) to generate solid plates. 405 
For intracellular metabolome analysis, B. subtilis cells were grown in NBG until mid-log phase. 108 406 
cells were collected on 0.22 µm filters and the transferred in NAG and incubated overnight at 30°C 407 
to allow replication and producing biomass. Then, the cells-laden filters were used as an unlabelled 408 
pre-culture control or placed in fresh NAG plates containing 20% U-13C-glucose (Sigma-Aldrich), with 409 
or without 200 µg/ml PenG and lysozyme, and incubated at 30 °C. The cells were collected at 0 (pre-410 
culture control), 45, 90 and 120 mins and polar metabolites were extracted in pre-chilled (-40 °C) 411 
methanol:acetonitrile:water solution as previously described 49.  412 
For exo-metabolome analysis, B. subtilis cultures were grown in NBG until mid-log phase and the 413 
culture filtrates were collected by 0.2 µm filters as an unlabelled pre-culture control. 108 cells were 414 
collected from the log phase cultures and re-suspended in fresh 4 ml NBG containing 20% U-13C-415 
glucose (Sigma-Aldrich), with or without 400 µg/ml PenG and lysozyme, and incubated at 30 °C. The 416 
culture filtrates were collected by 0.2 µm filters at 45, 90 and 120 mins and then diluted 1:3 with 417 
methanol:acetonitrile:water solution. 418 
The liquid chromatography-mass spectrometry was performed with a modified protocol described 419 
previously 50. Briefly, aqueous normal phase liquid chromatography was performed using an Agilent 420 
1200 LC system at controlled temperature (4 °C). Flow rate of 0.4 mL/min was used. Elution polar 421 
were performed using a gradient of two solvents, A (mQ water and 0.1 % of formic acid) and B 422 
(acetonitrile and 0.1 % of formic acid). The accurate mass spectrometry was performed using an 423 
Agilent Accurate Mass 6230 TOF apparatus equipped with Dual Agilent Jet Stream ESI source. The 424 
data were analysed by Profinder B.08.00 software and Mass Hunter Qualitative Analysis B07.00. The 425 
metabolites were identified comparing the accurate m/z (error <10 ppm) and the retention time 426 
with the accurate m/z and the retention time of standard solutions for the specific metabolite. The 427 
metabolites were quantified using standards calibration curves and then were normalised over total 428 
ion counts present in each extract. Since the bacillithiol standard is not commercially available, the 429 
identification of this molecule (the reduced form, monomer) was based on m/z only. We could not 430 
detect the oxidised form (dimer). 431 
 432 
Data availability 433 
The data that support the findings of this study are available from the corresponding author upon 434 
request. 435 
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Figure legends 589 
Figure 1. Blocking PG synthesis causes glycolysis-mediated cell death 590 
a, Schematic representation of the drains on carbon in the central metabolic pathway in B. subtilis.  591 
b, Effects of repression of ispA on cell growth in the walled and L-form states. B. subtilis strains 592 
BS115 (Pxyl-murE ispA+) and LR2 (Pxyl-murE ispA-) were streaked on NA/MSM (sucrose) plates with 593 
(MurE ON) or without (MurE OFF) 1% xylose and incubated at 30°C (left and middle panels). Phase 594 
contrast micrographs of LR2 (right panels) were taken from the plates with (MurE ON) or without 595 
(MurE OFF) xylose shown in middle. 596 
c, Effects of repression of gapA on cell growth in the walled and L-form states. B. subtilis strain 597 
YK1621 (Pxyl-murE PspacHY-gapA) was streaked on NA/MSM (sucrose) plates with (GapA ON) or 598 
without (GapA OFF) 1 mM IPTG, and also in the presence (MurE ON) or absence (MurE OFF) of 1% 599 
xylose and incubated at 30°C. Phase contrast micrographs of YK1621 (right panels) were taken from 600 
the plates without IPTG (GapA OFF), and in the presence (MurE ON) or absence (MurE OFF) of xylose 601 
shown in middle. 602 
d, Schematic representation of UDP-GlcNAc pathway in B. subtilis. 603 
e, Effects of repression of glmM on L-form growth. B. subtilis strains YK1563 (Pxyl-murE ispA- Pspac-604 
glmM), YK1763 (YK1563 ndh-), YK1764 (YK1563 qoxB-), YK1765 (YK1563 ctaB-) and YK1995 (YK1563 605 
mhqR-) were streaked on NA/MSM plates with (GlmM ON) or without (GlmM OFF) 1 mM IPTG in the 606 
absence of xylose (MurE OFF) and incubated at 30°C. 607 
The figures are representative of at least three independent experiments (b, c and e). 608 
Figure 2. The glycolysis-mediated cell death is suppressed under gluconeogenic conditions  609 
a, Effects of repression of sugar uptake system, PTS, on L-form growth. B. subtilis strains YK1601 610 
(Pxyl-murE Pspac-ptsHI), YK1602 (Pxyl-murE ΔptsG), YK2124 (Pxyl-murE ΔsacP), YK2125 (Pxyl-murE ΔfruA) 611 
and YK2126 (Pxyl-murE ΔlevD) were streaked on NA/MSM (sucrose) plates with or without 1 mM 612 
IPTG, and in the presence (MurE ON) or absence (MurE OFF) of 1% xylose, and incubated at 30°C. No 613 
effects were observed in the walled cell growth in the presence of IPTG and xylose.  614 
b, Phase contrast micrographs of YK1601 were taken from the plates without IPTG and xylose shown 615 
in panel a. 616 
c, Effects of additional carbon sources on L-form growth on a complex rich medium (NA). B. subtilis 617 
strains BS115 (Pxyl-murE ispA+) and LR2 (Pxyl-murE ispA-) were streaked on NA plates with 0.5 M 618 
various carbon sources (sucrose, glucose, malate or succinate) in the absence of xylose (MurE OFF), 619 
and incubated at 30°C.  620 
d, Phase contrast micrographs of BS115 or LR2 were taken from the plates shown in panel c. 621 
The figures are representative of at least three independent experiments (a-d). 622 
Figure 3. L-form growth under gluconeogenic conditions  623 
a, B. subtilis wild-type L-form growth on succinate plates containing PenG and lysozyme. B. subtilis 624 
wild-type strain (168CA; murE+ ispA+) was streaked on NA/succinate plates with or without 200 625 
μg/ml PenG, or PenG and 100 μg/ml chicken egg white lysozyme (Lys), and incubated at 30°C for 2-3 626 
days.  627 
b, Phase contrast micrographs of walled cells (i) and L-forms (ii) were taken from the plates shown in 628 
panel a (PenG/Lys). 629 
c, Effects of glucose on L-form transition of B. subtilis wild-type strain. Exponentially growing B. 630 
subtilis wild-type cells were placed on NA/glucose with PenG and lysozyme for time-lapse 631 
microscopy. Individual frames are extracted from Supplementary Video 1. Numbers in the top right 632 
corner of each frame represent time (min) elapsed in the movie. 633 
d, Effects of succinate on L-form transition of B. subtilis wild-type strain. Exponentially growing B. 634 
subtilis wild-type cells were placed on NA/succinate with PenG and lysozyme for time-lapse 635 
microscopy. Individual frames are extracted from Supplementary Video 1. Numbers in the top right 636 
corner of each frame represent time (min) elapsed in the movie. 637 
e, f, Effects of L-form transition on oxidative damage in B. subtilis wild-type strain. Exponentially 638 
growing B. subtilis wild-type cells in NB/glucose (e) or NB/succinate (f) were treated with PenG and 639 
lysozyme. The fluorescent probe C11-BODIPY581/591 was used as an indicator of lipid peroxidation. The 640 
probe undergoes a shift from red to green fluorescence emission upon peroxidation. 641 
The figures are representative of at least two independent experiments (a-f). 642 
Figure 4. Increase in glycolytic flux and ROS toxicity during L-form transitions 643 
a, b, Effects of the L-form transition on glycolysis in B. subtilis. The charts show the pool size of 644 
labelled (13C, red) and unlabelled (12C, blue) intracellular pyruvate (a), or secreted extracellular 645 
pyruvate (b) from ~108 cells of B. subtilis wild-type (168CA) and ispA- (RM81) cultures in NB/glucose 646 
with or without PenG (P) and lysozyme (L). Pre-cultures of B. subtilis in the presence 0.4 M 647 
unlabelled glucose were also analysed as a control for the pyruvate levels before incubation in the 648 
presence of labelled glucose (Pre.). The concentrations were normalised over total ion counts. The 649 
bars represent the averages and the standard deviation from four biological replicates. The p value 650 
(two-sided) was calculated using a student t test. To ensure that cell lysis did not contribute to the 651 
extracellular values we also measured succinate and found diminished (rather than increased) 652 
extracellular levels in the presence of PenG and lysozyme (Supplementary Table 1). 653 
c, Effects of the L-form transition on intracellular bacillithiol. Samples from the above experiment 654 
were analysed for total pool size of intracellular bacillithiol from ~108 cells of B. subtilis cultures. The 655 
identification of bacillithiol was based on m/z ion counts, which were normalised over total ion 656 
counts. The bars represent the averages and the standard deviation from four biological replicates. 657 
Figure 5. S. aureus escapes from β-lactam killing under gluconeogenic conditions 658 
a, Effects of carbon sources on S. aureus L-form growth. S. aureus strain RN4220 was streaked on 659 
NA/glucose (Glu) or succinate (Suc) plates with or without 200 μg/ml PenG and/or 10 μg/ml 660 
lysostaphin, and incubated at 30°C for 2-3 days.  661 
b, Phase contrast micrographs of S. aureus cells on NA/succinate plates with or without PenG and 662 
lysostaphin were taken from the plates shown in panel a. 663 
c, Growth profiles of S. aureus cells in NB/glucose (Glu) or succinate (Suc) with or without 100 μg/ml 664 
PenG (left panel), or PenG and 10 μg/ml lysostaphin (right panel). S. aureus cells were incubated at 665 
30°C without shaking. 666 
d, The overnight cultures of S. aureus cells in NB/glucose (panel c, i) or succinate (panel c, ii) with 667 
PenG and lysostaphin were placed on NA/glucose (i) or succinate (ii), and incubated at 30°C for 3 668 
days. Phase contrast micrograph of S. aureus L-forms was taken from the NA/succinate plates (iii). 669 
e, Relative PenG sensitivity of S. aureus in NB/glucose (Glu) compared to NB/succinate (Suc). Time 670 
course measurements of CFU (ml-1) in S. aureus cultures (panel c, left) after addition of PenG were 671 
shown as a percentage of the survivors for the cells before PenG treatment (time 0) in the same 672 
cultures.  673 
f, S. aureus cells in NB/glucose (Glu) or succinate (Suc) after addition of PenG (panel c, left) were 674 
diluted (10-fold series) and 10 µl spots were placed on NA/Glu or Suc plates, respectively, and 675 
incubated at 30°C for 2-3 days. 676 
The figures are representative of at least three independent experiments (a-f). 677 
Figure 6. Bacteria lacking the RC pathway evades glycolysis-mediated β-lactam killing  678 
a, Effects of carbon sources on L. monocytogenes L-form growth. L. monocytogenes wild-type EDGe 679 
and EDGe ΔpgdA Δoat double mutant were streaked on NA/glucose (Glu) or succinate (Suc) plates 680 
with or without 200 μg/ml PenG and/or 100 μg/ml lysozyme (Lys), and incubated at 30°C for 2-3 681 
days.  682 
b, Phase contrast micrographs were taken from the plates shown in panel a. 683 
c, Effects of carbon sources on E. faecium L-form growth. E. faecium (ATCC19434) was streaked on 684 
NA/glucose (Glu) or succinate (Suc) plates with or without 200 μg/ml PenG and/or 100 μg/ml 685 
lysozyme, and incubated at 30°C for 2-3 days. Phase contrast micrographs were taken from the 686 
plates shown in left. 687 
The figures are representative of at least three independent experiments (a-c). 688 
 689 
Supplementary Information 690 
Supplementary Figure 1-4, Supplementary Video 1, Supplementary Table 1-3 and Supplementary 691 
references. 692 
 693 
 694 
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